Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 810 | 904 | 1,160 | 2,081 | 3,040 |
Operating Income | -810 | -904 | -1,160 | -2,081 | -3,040 |
Other Income | 26 | 38 | -390 | 161 | 1,271 |
Pre-tax Income | -784 | -866 | -1,550 | -1,920 | -1,769 |
Net Income Continuous | -784 | -866 | -1,550 | -1,920 | -1,769 |
Net Income | $-784 | $-866 | $-1,550 | $-1,920 | $-1,769 |
EPS Basic Total Ops | -0.67 | -1.31 | 31.28 | -4.88 | -5.21 |
EPS Basic Continuous Ops | -0.67 | -1.31 | 31.31 | -4.90 | -5.22 |
EPS Diluted Total Ops | -0.67 | -1.31 | 31.28 | -4.88 | -5.21 |
EPS Diluted Continuous Ops | -0.67 | -1.31 | 31.31 | -4.90 | -5.22 |
EPS Diluted Before Non-Recurring Items | -0.67 | -1.31 | N/A | -4.88 | -13.52 |
EBITDA(a) | $-810 | $-904 | $-1,160 | $-2,081 | $-3,040 |